









시장가
/
주식
/
nasdaq-abbv
/

AbbVie Inc

ABBV

228.070USD

+2.430+1.08%

시장 운영 시간 （ET）시세는 15분 지연됩니다

403.08B시가총액

171.83P/E TTM



AbbVie Inc

228.070

+2.430+1.08%

개요 금융 분석 회사

개요

금융

분석

회사

자세한 내용은 AbbVie Inc 회사

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

AbbVie Inc 정보



종목 코드 ABBV

회사 이름AbbVie Inc

상장일Jan 02, 2013

CEOMichael (Robert A)

직원 수55000

유형Ordinary Share

회계 연도 종료Jan 02

주소1 N Waukegan Rd

도시NORTH CHICAGO

증권 거래소NASDAQ OMX NASDAQ Basic NYSE

국가United States of America

우편 번호60064

전화18479327900

웹사이트https://www.abbvie.com/

종목 코드 ABBV

상장일Jan 02, 2013

CEOMichael (Robert A)

AbbVie Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Dr. Azita Saleki-Gerhardt, Ph.D.

Executive Vice President, Chief Operations Officer

183.77K

Mr. Thomas C. (Tom) Freyman, CPA

Independent Director

134.63K

+1203.00%

Mr. Edward J. (Ed) Rapp

Independent Director

42.95K

+1203.00%

Dr. Roopal Thakkar, M.D.

Executive Vice President - Research & Development, Chief Scientific Officer

42.28K

+5877.00%

Ms. Roxanne S. Austin, CPA

Lead Independent Director

38.46K

+1203.00%

Dr. Robert J. Alpern, M.D.

Independent Director

35.65K

+1203.00%

Mr. Frederick H. (Rick) Waddell

Independent Director

28.96K

+1203.00%

Ms. Melody B. Meyer

Independent Director

16.50K

+1203.00%

Mr. Timothy J. Richmond

Chief Human Resources Officer, Executive Vice President

6.13K

-21250.00%

Ms. Jennifer L. Davis

Independent Director

2.52K

+1203.00%

이름

이름/직위

직위

주식 보유

변동

Dr. Azita Saleki-Gerhardt, Ph.D.

Executive Vice President, Chief Operations Officer

183.77K

Mr. Thomas C. (Tom) Freyman, CPA

Independent Director

134.63K

+1203.00%

Mr. Edward J. (Ed) Rapp

Independent Director

42.95K

+1203.00%

Dr. Roopal Thakkar, M.D.

Executive Vice President - Research & Development, Chief Scientific Officer

42.28K

+5877.00%

Ms. Roxanne S. Austin, CPA

Lead Independent Director

38.46K

+1203.00%

Dr. Robert J. Alpern, M.D.

Independent Director

35.65K

+1203.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Immunology-SKYRIZI

4.71B

29.84%

Immunology-RINVOQ

2.18B

13.84%

Immunology-HUMIRA

993.00M

6.29%

Neuroscience-Botox Therapeutic

985.00M

6.24%

Neuroscience-Vraylar

934.00M

5.92%

기타

5.97B

37.85%

지역별USD

이름

수익

비율

United States

11.53B

73.07%

International

3.35B

21.21%

All other countries

660.00M

4.18%

Collaboration revenue

243.00M

1.54%

사업별

지역별

사업별USD

이름

수익

비율

Immunology-SKYRIZI

4.71B

29.84%

Immunology-RINVOQ

2.18B

13.84%

Immunology-HUMIRA

993.00M

6.29%

Neuroscience-Botox Therapeutic

985.00M

6.24%

Neuroscience-Vraylar

934.00M

5.92%

기타

5.97B

37.85%

주식 보유 통계

마지막 업데이트: Sun, Nov 16

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

10.18%

BlackRock Institutional Trust Company, N.A.

5.25%

State Street Investment Management (US)

4.52%

Geode Capital Management, L.L.C.

2.29%

JP Morgan Asset Management

2.06%

기타

75.70%

주주

비율

The Vanguard Group, Inc.

10.18%

BlackRock Institutional Trust Company, N.A.

5.25%

State Street Investment Management (US)

4.52%

Geode Capital Management, L.L.C.

2.29%

JP Morgan Asset Management

2.06%

기타

75.70%

주주 유형

주주

비율

Investment Advisor

43.82%

Investment Advisor/Hedge Fund

20.47%

Research Firm

3.08%

Bank and Trust

2.30%

Pension Fund

2.27%

Sovereign Wealth Fund

1.41%

Hedge Fund

0.92%

Insurance Company

0.70%

Family Office

0.20%

기타

24.83%

기관 주식 보유



마지막 업데이트: Mon, Dec 8

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

5311

1.33B

74.86%

+1.37M

2025Q3

5386

1.32B

74.95%

+8.86M

2025Q2

5326

1.32B

74.78%

+2.41M

2025Q1

5334

1.32B

74.15%

+3.84M

2024Q4

5267

1.31B

73.92%

+9.35M

2024Q3

4970

1.30B

74.13%

-1.24M

2024Q2

4907

1.30B

73.33%

+14.47M

2024Q1

4916

1.28B

72.48%

+1.37M

2023Q4

4861

1.27B

72.12%

+10.24M

2023Q3

4666

1.27B

72.28%

+8.75M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

176.93M

10.01%

+427.57K

+0.24%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

92.78M

5.25%

+679.67K

+0.74%

Sep 30, 2025

State Street Investment Management (US)

79.82M

4.52%

-202.47K

-0.25%

Sep 30, 2025

Geode Capital Management, L.L.C.

40.44M

2.29%

+1.26M

+3.22%

Sep 30, 2025

JP Morgan Asset Management

36.42M

2.06%

-1.05M

-2.81%

Sep 30, 2025

Charles Schwab Investment Management, Inc.

25.96M

1.47%

-825.22K

-3.08%

Sep 30, 2025

Capital Research Global Investors

25.23M

1.43%

-34.75K

-0.14%

Sep 30, 2025

Morgan Stanley Smith Barney LLC

23.97M

1.36%

+460.64K

+1.96%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

23.10M

1.31%

-1.99M

-7.94%

Jun 30, 2025

Fidelity Management & Research Company LLC

19.95M

1.13%

+301.27K

+1.53%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 40.87B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Oct 31, 2025

ABBV.NB Interim Cash Dividend of gross USD 1.73 paid on Feb 17, 2026 going ex on Jan 16, 2026 with reinvestment option

Jan 16, 2026

Feb 17, 2026

Jan 16, 2026

Sep 05, 2025

ABBV.NB Final Cash Dividend of gross USD 1.64 paid on Nov 14, 2025 going ex on Oct 15, 2025 with reinvestment option

Oct 15, 2025

Nov 14, 2025

Oct 15, 2025

Jun 20, 2025

ABBV.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option

Jul 15, 2025

Aug 15, 2025

Jul 15, 2025

Feb 13, 2025

ABBV.NB Interim Cash Dividend of gross USD 1.64 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option

Apr 15, 2025

May 15, 2025

Apr 15, 2025

Oct 30, 2024

ABBV.NB Interim Cash Dividend of gross USD 1.64 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Oct 30, 2024

ABBV.NB Interim Cash Dividend of gross USD 1.64 paid on Feb 14, 2025 going ex on Jan 15, 2025

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Sep 06, 2024

ABBV.NB Final Cash Dividend of gross USD 1.55 paid on Nov 15, 2024 going ex on Oct 15, 2024 with reinvestment option

Oct 15, 2024

Nov 15, 2024

Oct 15, 2024

Jun 21, 2024

ABBV.NB Interim Cash Dividend of gross USD 1.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option

Jul 15, 2024

Aug 15, 2024

Jul 15, 2024

Feb 15, 2024

ABBV.NB Interim Cash Dividend of gross USD 1.55 paid on May 15, 2024 going ex on Apr 12, 2024 with reinvestment option

Apr 15, 2024

May 15, 2024

Apr 12, 2024

Oct 27, 2023

ABBV.NB Interim Cash Dividend of gross USD 1.55 paid on Feb 15, 2024 going ex on Jan 12, 2024 with reinvestment option

Jan 16, 2024

Feb 15, 2024

Jan 12, 2024

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

KeyAI



AbbVie Inc

자세한 내용은 AbbVie Inc 회사

AbbVie Inc 정보

AbbVie Inc의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할